↓ Skip to main content

HER2-Testung beim Magenkarzinom

Overview of attention for article published in Die Pathologie, July 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
6 Mendeley
Title
HER2-Testung beim Magenkarzinom
Published in
Die Pathologie, July 2016
DOI 10.1007/s00292-016-0179-3
Pubmed ID
Authors

G. Baretton, M. Dietel, T. Gaiser, T. Kirchner, H. H. Kreipe, A. Quaas, C. Röcken, J. Rüschoff, A. Tannapfel, F. Lordick, S. Al-Batran, R. Hofheinz, S. Lorenzen, M. Moehler, P. Thuss-Patience

Abstract

Valid HER2 testing is essential for the optimal care of patients with HER2-positive gastric cancer and the correct use of first-line treatment. Although all cases of breast cancer are routinely tested for the HER2 status, HER2 testing in gastric cancer has still not become part of the routine and is usually only done upon request by the therapist. An interdisciplinary group of German experts has taken on the challenges of HER2 testing in gastric cancer as an opportunity to address essential aspects and questions on the practical use of HER2 testing in this indication from the perspective of pathologists and therapists. The recommendations made in this article reflect the consensus of all participants and correspond to their opinions and long-term experience.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 17%
Researcher 1 17%
Lecturer > Senior Lecturer 1 17%
Unknown 3 50%
Readers by discipline Count As %
Medicine and Dentistry 2 33%
Unknown 4 67%